CareLit Fachartikel

Neuroendocrine secretory profiles are not associated with treatment response to Lu-177-PSMA-617 radioligand therapy in patients with advanced metastatic castration-resistant prost…

T Derlin, R Werner, C Henkenberens, TL Ross, FM Bengel · Nuklearmedizin - NuclearMedicine · 2020 · Heft 02

Dokument
1214862
CareLit-ID
Jahr
2020
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Nuklearmedizin - NuclearMedicine
Autor:innen
T Derlin, R Werner, C Henkenberens, TL Ross, FM Bengel
Ausgabe
Heft 02 / 2020
Jahrgang 59
Seiten
–
Erschienen: 2020-04-01 00:00:00
ISSN
0029-5566
DOI
10.1055/s-0040-1708342

Zusammenfassung

Neuroendocrine secretory profiles are not associated with treatment response to Lu-177-PSMA-617 radioligand therapy in patients with advanced metastatic castration-resistant prostate cancer

Schlagworte

Neuroendocrine Secretory Profiles Associated Treatment Response Lu-177-Psma-617 Radioligand Therapy Patients Advanced Metastatic Nuklearmedizin - NuclearMedicine